Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 MAR 23 ... deadliest bioterror and pandemic threats. These include: Dengue hemorrhagic fever (DHF), Ebola hemorrhagic fever (EHF), Lassa hemorrhagic fever (LHF), H5N1 avian influenza (Bird Flu), ... of the “first-in-man” study of the Aethlon Hemopurifier® to treat Human Immunodeficiency Virus (HIV), the disease that causes Acquired Immune Deficiency Syndrome (AIDS). In the study, ... care, the Hemopurifier® is a leading broad-spectrum treatment candidate against drug and vaccine resistant viral pathogens.
“Our first HIV treatment experience supports ...
2009 AUG 10 ... studies against hemorrhagic fever viruses, including the highly virulent Zaire strain of Ebola (ZEBOV). Hemorrhagic viruses are potential bioterror and pandemic threats, whose ... strains of ZEBOV from fluids during one hour in vitro studies. ZEBOV has the highest virus case-fatality rate, up to 90% in some epidemics, with an average case fatality rate of ... it provides a therapeutic option against infectious viruses not addressed by drug and vaccine therapies. The objectives of the USAMRIID agreement include determining the ...
2009 AUG 17 ... the emergence of West Nile virus and Babesia spp, and the periodic emergence of Ebola and SARS as well as the bioterrorism potential have highlighted a persistent concern in ... Nile Virus, Zoonoses, Aphios Corporation. This article was prepared by AIDS Vaccine Week editors from staff and other reports. Copyright 2009, AIDS Vaccine Week via ...
2009 AUG 24 ... "The filoviruses Marburg virus and Ebolavirus cause severe hemorrhagic fever with high mortality in humans and nonhuman ... study in order to determine the potential of having one single-injection vaccine capable of protecting nonhuman primates against Sudan ebolavirus (SEBOV), Zaire ...
2009 MAY 11 ... H5N1 bird flu, seasonal Influenza, HIV, EKC, Hepatitis C, Rabies, Dengue fever, and Ebolavirus, among others.
Keywords: AIDS, Acquired Immunodeficiency Syndrome, ... Research, Virology, NanoViricides Inc.
This article was prepared by AIDS Vaccine Week editors from staff and other reports. Copyright 2009, AIDS Vaccine Week via ...
2009 OCT 5 ... of the eye including EKC and herpes simplex; Hepatitis C, Rabies, Dengue fever, and Ebolavirus, among others. Keywords: HIV/AIDS Co-Infection, Health, AIDS, ... provides a wide range of research services that include anti-infective drug and vaccine discovery, preclinical drug development, and basic research initiatives in microbiology, ...
2009 MAY 18 ... "We previously generated a replication-deficient, biologically contained Ebolavirus, Ebola Delta VP30, which lacks the essential VP30 gene, grows only in cells stably expressing ... Ebola Delta VP30 were protected from a lethal infection of mouse-adapted Ebolavirus. Virus titers in the serum of vaccinated mice were significantly lower than those in ... hemorrhagic fever, with case fatality rates as high as 90%. Currently, no licensed vaccine is available against Ebolavirus," researchers in the United States report.
...
2009 FEB 9 ... According to recent research from the United States, "Ebolavirus (EBOV) is a significant human pathogen that presents a public health concern as an ... protect nonhuman primates against EBOV."
"Among these prospects, a vaccine based on recombinant vesicular stomatitis virus (VSV) is particularly robust, as it can ...
2009 JAN 12 ... glycans that in viruses such as human immunodeficiency virus type 1 and Ebolavirus influence viral tropism and the host immune response. Nevertheless, we find ... Analysis of Nipah Virus Attachment Glycoprotein: a Template for Antiviral and Vaccine Design. Journal of Virology, 2008;82(23):11628-11636).
For more ...
2009 JAN 26 ... stage, directed to the treatment of viral hemorrhagic fever caused by viruses such as Ebola and Marburg, as well as the treatment of sepsis and septic shock. TOSAP(TM) is a novel, ... the prophylaxis and treatment of respiratory infections by all variations of influenza virus, including the types of virus that may cause a potential influenza pandemic. In ... a serious respiratory illness similar to influenza and for which there is no approved vaccine or therapeutic. Fludase(R) is a recombinant fusion protein that inactivates viral ...
2009 APR 27 ... PNWRCE researchers will study a broad range of diseases and viruses, including Ebola, Dengue, SARS, avian and 1918 influenza, dengue fever, yellow fever, and West Nile, all ... examples would include threats posed in the past few years by influenza, West Nile virus and SARS."
Members of the PNWRCE will work closely with public health ... Institutes of Health. Jay Nelson, Ph.D., is director of the PNWRCE and OHSU's Vaccine and Gene Therapy Institute (VGTI), and Michael Katze, Ph.D., UW professor of ...
2009 MAR 16 ... "Ebolavirus-like particles (VLPs) were produced in insect cells using a recombinant ... high production yields, and lend further Support to their development as an effective vaccine strategy against Ebola virus."
Sun and colleagues published their ...
2009 MAR 23 ... a study from the United States, "We generated a new live-attenuated vaccine against Ebolavirus (EBOV) based on a chimeric virus HPIV3/Delta F-HN/EboGP that contains the EBOV ...
2009 FEB 8 ... in developing candidate preventive vaccines that can protect nonhuman primates against Ebola and Marburg viruses. A vaccine based oil recombinant vesicular stomatitis virus (VSV) ...
2009 JUL 6 ... of Texas Medical Branch at Galveston have discovered two biochemical pathways that the Ebolavirus relies on to infect cells. Using substances that block the activation of those ... fever on its victims, producing 90 percent mortality rates in some outbreaks. No vaccine exists for the virus, and it is considered a high-risk agent for bioterrorism. Natural ...
Subject: University of Texas Medical Branch at Galveston
2009 SEP 7 ... as CD45, can provide protection against two divergent microbes: the virus that causes Ebola hemorrhagic fever and the bacterium that causes anthrax. Taken together, the results ... gastrointestinal, and inhalational-depending upon the route of exposure. A licensed vaccine is available, and is protective if administered before exposure. Inhalational anthrax is ...
Subject: US Army Medical Research Institute of Infectious Diseases
2009 JAN 26 ... According to recent research from Winnipeg, Canada, "Human infections with Ebolavirus (EBOV) result in a deadly viral disease known as Ebola hemorrhagic fever. Up to ... fever. Up to 90% of infected patients die, and there is no available treatment or vaccine."
"The sporadic human outbreaks are believed to result when EBOV ...
2009 MAY 18 ... and strains of enveloped viruses, like human, avian and swine Influenzas, SARS, AIDS, Ebola and smallpox viruses. VCCD Tech uses a mechanism of action that greatly limits the ... i.e. 100 times better and a peak performance of 1000 times, against avian influenza virus H5N1. Disposable facemasks are thus far not very effective against viruses, such as ... Viral Therapy, Virology, Viroblock Sa.
This article was prepared by AIDS Vaccine Week editors from staff and other reports. Copyright 2009, AIDS Vaccine Week via ...
2009 APR 13 ... on all families of enveloped viruses, such as human and avian influenzas, SARS, AIDS, Ebola and smallpox viruses."
"This is an exciting development period for ... Clinical Trial Research, Clinical Trials, Flu, HIV, Human Immunodeficiency Virus, Human Influenza, Immunization, Influenza, Patents Actions, Pre-Trials Research, ... Viral Therapy, Virology, Viroblock Sa.
This article was prepared by AIDS Vaccine Week editors from staff and other reports. Copyright 2009, AIDS Vaccine Week via ...
2009 MAY 4 ... in the report. Forecast for the future market size of vaccine for diseases like Malaria, Ebola, Tuberculosis (TB), Japanese Encephalitis, West Nile, Typhoid etc. which are yet to be ... Vaccines, Cervical Carcinoma, Cutaneous Tuberculosis, Ebola Hemorrhagic Fever, Ebola Virus, Encephalitis, Gastroenterology, HBV, Hematology, Hepatitis B Virus, Hepatology, ...
